Nasdaq · Common stock
Seaport Therapeutics (SPTX)
$20.83 +$0.22 (+1.07%)
- Day’s range
- $20.34–$21.69
- Volume
- 124,685
SPTX price history
SPTX closed at $20.83 on Oct. 26, 2026. Over the past year, its daily close ranged from $15.25 on May 11, 2026 to $27.84 on Aug. 26, 2026.
Data table: SPTX daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $20.83 |
| Oct. 23, 2026 | $20.61 |
| Oct. 22, 2026 | $20.76 |
| Oct. 21, 2026 | $19.73 |
| Oct. 20, 2026 | $19.28 |
| Oct. 19, 2026 | $17.79 |
| Oct. 16, 2026 | $17.83 |
| Oct. 15, 2026 | $17.60 |
| Oct. 14, 2026 | $16.68 |
| Oct. 13, 2026 | $16.08 |
| Oct. 12, 2026 | $17.15 |
| Oct. 9, 2026 | $18.15 |
| Oct. 8, 2026 | $17.91 |
| Oct. 7, 2026 | $17.93 |
| Oct. 6, 2026 | $17.37 |
| Oct. 5, 2026 | $18.50 |
| Oct. 2, 2026 | $18.42 |
| Oct. 1, 2026 | $18.95 |
| Sept. 30, 2026 | $20.17 |
| Sept. 29, 2026 | $18.69 |
| Sept. 28, 2026 | $19.64 |
| Sept. 25, 2026 | $21.52 |
| Sept. 24, 2026 | $21.12 |
| Sept. 23, 2026 | $21.29 |
| Sept. 22, 2026 | $22.39 |
| Sept. 21, 2026 | $21.12 |
| Sept. 18, 2026 | $21.39 |
| Sept. 17, 2026 | $21.82 |
| Sept. 16, 2026 | $22.14 |
| Sept. 15, 2026 | $22.96 |
| Sept. 14, 2026 | $24.70 |
| Sept. 11, 2026 | $23.34 |
| Sept. 10, 2026 | $23.28 |
| Sept. 9, 2026 | $21.75 |
| Sept. 8, 2026 | $24.06 |
| Sept. 4, 2026 | $24.86 |
| Sept. 3, 2026 | $24.29 |
| Sept. 2, 2026 | $24.91 |
| Sept. 1, 2026 | $23.61 |
| Aug. 31, 2026 | $23.68 |
| Aug. 28, 2026 | $24.04 |
| Aug. 27, 2026 | $26.25 |
| Aug. 26, 2026 | $27.84 |
| Aug. 25, 2026 | $24.83 |
| Aug. 24, 2026 | $24.08 |
| Aug. 21, 2026 | $24.31 |
| Aug. 20, 2026 | $24.04 |
| Aug. 19, 2026 | $24.42 |
| Aug. 18, 2026 | $23.97 |
| Aug. 17, 2026 | $24.40 |
| Aug. 14, 2026 | $24.22 |
| Aug. 13, 2026 | $23.71 |
| Aug. 12, 2026 | $23.80 |
| Aug. 11, 2026 | $23.36 |
| Aug. 10, 2026 | $23.02 |
| Aug. 7, 2026 | $23.62 |
| Aug. 6, 2026 | $23.09 |
| Aug. 5, 2026 | $22.34 |
| Aug. 4, 2026 | $21.43 |
| Aug. 3, 2026 | $20.65 |
| July 31, 2026 | $20.46 |
| July 30, 2026 | $20.32 |
| July 29, 2026 | $19.74 |
| July 28, 2026 | $19.90 |
| July 27, 2026 | $20.54 |
| July 24, 2026 | $21.10 |
| July 23, 2026 | $21.94 |
| July 22, 2026 | $21.30 |
| July 21, 2026 | $21.00 |
| July 20, 2026 | $20.55 |
| July 17, 2026 | $20.85 |
| July 16, 2026 | $19.52 |
| July 15, 2026 | $20.45 |
| July 14, 2026 | $20.44 |
| July 13, 2026 | $20.10 |
| July 10, 2026 | $21.58 |
| July 9, 2026 | $20.51 |
| July 8, 2026 | $21.26 |
| July 7, 2026 | $18.23 |
| July 6, 2026 | $19.37 |
| July 2, 2026 | $20.57 |
| July 1, 2026 | $21.45 |
| June 30, 2026 | $21.72 |
| June 29, 2026 | $22.52 |
| June 26, 2026 | $21.40 |
| June 25, 2026 | $19.36 |
| June 24, 2026 | $19.31 |
| June 23, 2026 | $18.97 |
| June 22, 2026 | $17.99 |
| June 18, 2026 | $18.17 |
| June 17, 2026 | $17.10 |
| June 16, 2026 | $17.97 |
| June 15, 2026 | $17.44 |
| June 12, 2026 | $18.00 |
| June 11, 2026 | $17.72 |
| June 10, 2026 | $17.12 |
| June 9, 2026 | $17.66 |
| June 8, 2026 | $16.20 |
| June 5, 2026 | $16.44 |
| June 4, 2026 | $17.88 |
| June 3, 2026 | $17.23 |
| June 2, 2026 | $17.21 |
| June 1, 2026 | $17.13 |
| May 29, 2026 | $18.19 |
| May 28, 2026 | $18.80 |
| May 27, 2026 | $18.05 |
| May 26, 2026 | $18.01 |
| May 22, 2026 | $17.50 |
| May 21, 2026 | $17.19 |
| May 20, 2026 | $15.78 |
| May 19, 2026 | $15.66 |
| May 18, 2026 | $15.74 |
| May 15, 2026 | $16.81 |
| May 14, 2026 | $16.94 |
| May 13, 2026 | $16.50 |
| May 12, 2026 | $15.95 |
| May 11, 2026 | $15.25 |
| May 8, 2026 | $16.05 |
| May 7, 2026 | $15.50 |
| May 6, 2026 | $16.00 |
| May 5, 2026 | $16.00 |
| May 4, 2026 | $17.00 |
| May 1, 2026 | $19.84 |
Key figures
- Average daily volume
- 195,627Past 3 months
- Market value
- $1.12B
- Dividend yield
- —
Price change
- 1 month
- −3.21%
- 3 months
- −1.28%
What Wall Street says about SPTX
In the past 90 days, Wall Street firms published 7 rating or price-target actions on SPTX: 3 new ratings and 4 reiterated ratings.
| Action | Rating | |||
|---|---|---|---|---|
| Canaccord Genuity | Initiates coverage | Buy | $28 | |
| HC Wainwright & Co. | Reiterates | Buy | $50 | |
| Raymond James | Initiates coverage | Strong buy | $46 | |
| HC Wainwright & Co. | Reiterates | Buy | $50 | |
| Jones Trading | Initiates coverage | Buy | $32 | |
| HC Wainwright & Co. | Reiterates | Buy | $50 | |
| HC Wainwright & Co. | Reiterates | Buy | $50 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Seaport Therapeutics, Inc. Common Stock
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
- Headquarters
- Boston, Mass.
- Listed
- May 1, 2026
- Sector
- Health care
- Industry
- Pharmaceutical preparations
In WallStreetDigest editions
No WallStreetDigest article about SPTX is on the site yet.